SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.

Claudia WinklerJoshua ArmeniaGemma N JonesLuis TobalinaMatthew J SaleTudor PetreusTarrion BairdVioleta SerraAnderson T WangAlan LauMathew J GarnettPatricia JaaksElizabeth A CokerAndrew J PierceMark J O'ConnorElisabetta Leo

Published in: British journal of cancer (2020)

SLFN11 informs on the standard of care chemotherapy based on DDA and the effect of selected combinations with ATR, WEE1 or CHK1 inhibitor in a wide range of cancer types and models.

Keyphrases

papillary thyroid
healthcare
palliative care
squamous cell
quality improvement
dna damage response
pain management
radiation therapy
oxidative stress
rectal cancer
chronic pain